These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10862783)

  • 1. Immune recognition of OxLDL in atherosclerosis.
    Kearney JF
    J Clin Invest; 2000 Jun; 105(12):1683-5. PubMed ID: 10862783
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylcholine-targeting immunization reduces atherosclerosis.
    Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
    J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the sialic acid content of low-density lipoprotein (LDL) and autoantibodies to oxidized LDL in the plasma of healthy subjects and patients with atherosclerosis.
    Cerne D; Jürgens G; Ledinski G; Kager G; Greilberger J; Lukac-Bajalo J
    Clin Chem Lab Med; 2002 Jan; 40(1):15-20. PubMed ID: 11916265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
    Caligiuri G; Nicoletti A; Poirier B; Hansson GK
    J Clin Invest; 2002 Mar; 109(6):745-53. PubMed ID: 11901183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arteriosclerosis -- an autoimmune disease?].
    Biedermann BC
    Praxis (Bern 1994); 2003 Oct; 92(42):1781-3. PubMed ID: 14598535
    [No Abstract]   [Full Text] [Related]  

  • 8. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
    Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
    Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J
    Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological aspects of atherosclerosis].
    Osipov SG
    Klin Med (Mosk); 1989 Jan; 67(1):27-37. PubMed ID: 2654462
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.
    Shaw PX; Hörkkö S; Chang MK; Curtiss LK; Palinski W; Silverman GJ; Witztum JL
    J Clin Invest; 2000 Jun; 105(12):1731-40. PubMed ID: 10862788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are immunological mechanisms relevant for the development of atherosclerosis?
    Witztum JL; Palinski W
    Clin Immunol; 1999 Feb; 90(2):153-6. PubMed ID: 10080825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immune complexes and arteriosclerosis].
    Osipov SG; Titov VN
    Kardiologiia; 1982; 22(7):119-25. PubMed ID: 6213809
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
    Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
    Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
    Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
    J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
    Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
    Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological aspects of arteriosclerosis].
    Korochkin IM; Selivanov II
    Sov Med; 1983; (6):47-52. PubMed ID: 6225194
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology.
    Craig WY
    J Clin Lab Anal; 1995; 9(1):70-4. PubMed ID: 7722776
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
    Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
    Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.